ClinicalTrials.Veeva

Menu

Light Therapy for Obsessive-compulsive Disorder (OCD) (KLTO)

The Washington University logo

The Washington University

Status and phase

Enrolling
Early Phase 1

Conditions

OCD

Treatments

Behavioral: Light therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06720090
K23MH137376 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this clinical trial is to test whether light therapy is effective for reducing symptoms in young adults with OCD and late bedtimes (1am or later). The main question[s] it aims to answer are:

Does light therapy reduce OCD symptoms? Does light therapy advance the circadian clock? If there is a comparison group: Researchers will compare a higher dose of light therapy to a lower dose to see if dose amount affects symptom reduction.

Participants will asked to:

  1. Wear light therapy glasses for 1 hour each morning and complete a daily light therapy log for 5 weeks
  2. Track their sleep every day with a wearable monitor and an electronic sleep diary for 5 weeks
  3. Complete a 1-time assessment of sensitivity to light exposure
  4. Complete self-report measures of OCD 4 times/day at baseline (2 weeks), mid-treatment (1 week), and end of treatment (1 week)

Enrollment

40 estimated patients

Sex

All

Ages

17 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Primary DSM-5 OCD diagnosis
  2. Bedtime 0100 or later
  3. Age 18-35
  4. English speaking

Exclusion criteria

  1. Subjects must not be currently participating in another research study that would influence their participation in our study.
  2. Diagnostic status
  3. Treatment status
  4. Night shift work or travel more than 1 time zone outside of Central Standard Time (CST) in the past month
  5. Pregnancy status
  6. Medication status
  7. Regular nicotine or marijuana use

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Higher dose
Experimental group
Description:
Participants will be given wearable light therapy devices that emit a higher light intensity.
Treatment:
Behavioral: Light therapy
Lower dose
Sham Comparator group
Description:
Participants will be given wearable light therapy devices that emit a lower light intensity.
Treatment:
Behavioral: Light therapy

Trial contacts and locations

1

Loading...

Central trial contact

Rebecca Cox, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems